palbociclib,sacituzumab govitecan,trastuzumab deruxtecan
astrazeneca,pfizer,gilead sciences,daiichi sankyo
['ibrance', 'breast', 'enhertu', 'trodelvy', 'gilead', 'astrazeneca', 'pfizer']
3 sets of trial data to be presented #asco22 meeting this weekend could shake up breast cancer treatment: breast cancer data from gilead sciences trodelvy, pfizer s ibrance and astrazeneca and daiichi sankyo s enhertu, read the preview.
#oncology #cancer 
Leadership and learning are indispensable to each other. John F. Kennedy